WINKAST-SF-500 LIFECAPS Capsule
MRP: 648
Packaging: 1X30caps
Pack Type: capsule
Composition:
Salmeterol 50mcg + Fluticasone 500mcg
Indication:
Used for long-term management of asthma and COPD to reduce airway inflammation and improve breathing.
Description:
This combination provides long-term control of asthma and chronic obstructive pulmonary disease (COPD).
Salmeterol keeps the airways open by relaxing bronchial smooth muscle.
Fluticasone reduces airway inflammation and swelling.
Together, they help improve lung function, reduce exacerbations, and relieve symptoms like wheezing and breathlessness.
Tags:
- Long-term symptom control
- Salmeterol (LABA) relaxes airway muscles, improving airflow and oxygen exchange in the lungs.
- Fluticasone (corticosteroid) decreases swelling and mucus buildup, leading to fewer breathing difficulties.
- Regular use lowers the frequency and severity of exacerbations or attacks.
- Improves breathing capacity, allowing better physical activity performance in chronic lung disease patients.
Usage Information
Dosage
Typical Dose: 1 inhalation twice daily (morning and evening) Administer via a dry powder inhaler (DPI) or metered dose inhaler (MDI) as prescribed Rinse mouth with water after use to prevent oral thrush Do not use as a rescue inhaler for acute bronchospasm
Side Effects
Common: Oral thrush (candidiasis) Hoarseness, throat irritation Headache Tremor or palpitations Cough Serious (rare): Paradoxical bronchospasm Adrenal suppression (long-term high doses) Decreased bone mineral density (long-term)
Contraindications
Hypersensitivity to salmeterol, fluticasone, or any excipients Acute status asthmaticus or severe acute COPD exacerbations (not for rescue use)
Availability
Salmeterol Fluticasone inhaler, LABA ICS combination, asthma COPD inhaler, salmeterol 50 fluticasone 500